Penn Pharma

Edward Rowland has been appointed head of operational analytical services for Penn Pharma. Mr. Rowland will manage a team of 45 analytical chemists that provide clients with analytical support across a wide variety of clinical and commercial product development programs. He joins the company from Wyeth Research in Gosport, Hampshire, and has 15 years of industry experience having held roles in R&D, commercial operations, and analytical development.

Mr. Rowland said, “Penn’s analytical development has over 25 year’s experience in provision of practical, effective and compliant analytical solutions for its clients and I am looking forward to building on this reputation for excellence in my new role.”

Mark Molyneux, acting chief executive officer and chairman of the board of directors at Penn Pharma added, “Edward joins Penn Pharma at a very exciting time. We have seen the company expand worldwide in recent years and Edward’s experience will greatly assist us in continuing to grow our market base by providing our clients with bespoke services and solutions that differentiate us from the competition.”